• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肠胃外给药的水包油型脂质乳剂。I. 油颗粒和掺入苏丹II的药代动力学

O/W lipid emulsions for parenteral drug delivery. I. Pharmacokinetics of the oil particles and incorporated sudan II.

作者信息

Sakaeda T, Takahashi K, Nishihara Y, Hirano K

机构信息

Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.

出版信息

Biol Pharm Bull. 1994 Nov;17(11):1490-5. doi: 10.1248/bpb.17.1490.

DOI:10.1248/bpb.17.1490
PMID:7703970
Abstract

The potential usefulness of oil in water (O/W) lipid emulsions as parenteral drug delivery system for lipophilic drugs was examined in tumor-bearing rats. A model lipophilic drug, sudan II (PCoct = 226000), was formulated in five lipid emulsions consisting of soybean oil and various surfactants. Compared with HCO-60 micellar and plasma solutions of sudan II, the blood concentration of sudan II was markedly elevated by administration as a lipid emulsion. However, the distribution of sudan II to the liver, lungs, spleen, and adipose tissue was not altered, and that to the brain, heart, kidneys, muscle, and tumor was slightly decreased. To understand these results, pharmacokinetic analysis was performed using a newly derived compartmental model, and moreover, the organ distribution clearance was analyzed. It was suggested that the oil particles deliver the incorporated drug selectively to the liver, lungs, and spleen, and the speed of delivery could be surpressed by using HCO-60. However, in the case of sudan II, its rapid release from the oil particles after i.v. injection prevented a drastic alteration in the distribution of sudan II. The simulation studies suggested that a considerable decrease in the release rate or an increase in partition coefficient (experimentally more than 10(8) would be required for delivery.

摘要

在荷瘤大鼠中研究了水包油(O/W)脂质乳剂作为亲脂性药物胃肠外给药系统的潜在用途。一种模型亲脂性药物苏丹II(正辛醇/水分配系数=226000)被制成由大豆油和各种表面活性剂组成的五种脂质乳剂。与苏丹II的HCO - 60胶束溶液和血浆溶液相比,以脂质乳剂形式给药后,苏丹II的血药浓度显著升高。然而,苏丹II在肝脏、肺、脾脏和脂肪组织中的分布没有改变,而在脑、心脏、肾脏、肌肉和肿瘤中的分布略有减少。为了解这些结果,使用新推导的房室模型进行了药代动力学分析,此外,还分析了器官分布清除率。结果表明,油颗粒将包封的药物选择性地输送到肝脏、肺和脾脏,并且使用HCO - 60可以抑制输送速度。然而,对于苏丹II,静脉注射后其从油颗粒中的快速释放阻止了苏丹II分布的剧烈改变。模拟研究表明,为了实现药物输送,释放速率需要大幅降低或分配系数需要增加(实验上大于10^8)。

相似文献

1
O/W lipid emulsions for parenteral drug delivery. I. Pharmacokinetics of the oil particles and incorporated sudan II.用于肠胃外给药的水包油型脂质乳剂。I. 油颗粒和掺入苏丹II的药代动力学
Biol Pharm Bull. 1994 Nov;17(11):1490-5. doi: 10.1248/bpb.17.1490.
2
O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug.用于肠胃外给药的水包油型脂质乳剂。II. 组成对包封药物药代动力学的影响。
J Drug Target. 1995;3(3):221-30. doi: 10.3109/10611869509015949.
3
O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection.用于肠胃外给药的水包油型脂质乳剂。III. 即使静脉注射后纳入油颗粒所需的亲脂性。
J Drug Target. 1998;6(2):119-27. doi: 10.3109/10611869808997887.
4
Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.静脉注射油包水脂质乳剂后,成分对油颗粒生物学转归的影响。
J Drug Target. 1998;6(4):273-84. doi: 10.3109/10611869808996835.
5
Effect of acyl chains of phosphatidylcholines on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with phosphatidylcholines and soybean oil in rats.磷脂酰胆碱的酰基链对在大鼠中用磷脂酰胆碱和大豆油制备的水包油脂质乳剂中维生素K4药代动力学的影响。
J Pharm Pharmacol. 2004 Jul;56(7):855-9. doi: 10.1211/0022357023790.
6
Effect of injection volume on the pharmacokinetics of oil particles and incorporated menatetrenone after intravenous injection as O/W lipid emulsions in rats.注射体积对大鼠静脉注射O/W脂质乳剂后油颗粒及包封的维生素K4药代动力学的影响。
J Drug Target. 2001;9(5):353-60. doi: 10.3109/10611860108998771.
7
Effect of oxyethylene moiety in polyoxyethylene sorbitan esters on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with polyoxyethylene sorbitan esters and soybean oil in rats.聚氧乙烯山梨醇酐酯中的氧乙烯部分对大鼠体内用聚氧乙烯山梨醇酐酯和大豆油制备的水包油型脂质乳剂中维生素K4药代动力学的影响。
J Pharm Pharmacol. 2002 Oct;54(10):1357-63. doi: 10.1211/002235702760345437.
8
O/W lipid emulsions for parenteral drug delivery. IV. Changes in the pharmacokinetics and pharmacodynamics of a highly lipophilic drug, menatetrenone.用于肠胃外给药的水包油型脂质乳剂。IV. 高度亲脂性药物维生素K4的药代动力学和药效学变化
J Drug Target. 1998;6(3):183-9. doi: 10.3109/10611869808997892.
9
Effect of particle size on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oils and soybean oil in rats.粒径对用氢化蓖麻油和大豆油制备的大鼠O/W脂质乳剂中维生素K4药代动力学的影响。
J Drug Target. 2003 May;11(4):241-6. doi: 10.1080/10611860310001617981.
10
Development of a Novel Spontaneous Emulsification Method for Peptide Delivery Using Porous Silica Particles.一种使用多孔二氧化硅颗粒进行肽递送的新型自发乳化方法的开发。
J Oleo Sci. 2018 Mar 1;67(3):303-306. doi: 10.5650/jos.ess17195. Epub 2018 Feb 19.